Introduction
Higher plants provide us with a large variety of valuable natural products such as flavors, insecticides, and pharmaceuticals. Despite remarkable advances in synthetic organic chemistry, plants are still the sole source of about 25% of prescribed medicines (1). Since it is generally possible to cultivate plant cells in large quantities under aseptic conditions, plant cell suspension cultures are regarded as potentially suitable systems for producing phytochemicals of high economic value (2, 3, 4).
Studies on the production of plant secondary metabolites by plant cell suspension cultures have been comprehensively described (5, 6) . Several plant cell cultures have been shown to produce large amounts of secondary metabolites (Table la) , but although the number of high-yielding cell cultures increases yearly, there are still plant species which fail to produce their important natural products when cultivated in the form of an undifferentiated cell culture (7, 8, 9; Table ib ). Many of these recalcitrant plant species provide us with very important natural products, such as codeine, quinine, tropane alkaloids, or cardiac glycosides. Hinokiol Diterpene (46) Abstract Plant cell cultures are a potential source of pharmaceutically important plant metabolites. In the past few years a lot of success has been achieved in the field of the cultivation of plant cells on a large scale. Special bioreactor systems, such as airlift or drum-type fermentors have been devised for the mass cultivation of plant cells. Classical stirred-tank bioreactors (up to 750001 volume) have also been used for the cultivation of plant cells and the production of important plant metabolites. Plant cells proliferate much slower than microbial cells. In consequence, the time taken to grow a plant cell suspension from the shake-flask level (300 ml) to the production scale (20, 0001) takes about 3 to 6 weeks. Nevertheless, the cost analyses available show that the production of valuable chemicals by a suitable plant cell culture process could be commercially viable. Plant cells have been grown in batch and repeated batch culture, and single-stage as well as two-stage processes have been developed for the production of secondary metabolites by fermentor-cultured plant cells. There are, however, only few cell culture processes that have attracted industrial attention as yet. Biological rather than technological problems are the main obstacles to a more common use of fermentorcultured plant cells in industry.
Some cell cultures produce secondary
metabolites not yet known to occur in the respective mother plants (5, 9, 10; Table lc ). This has prompted some research groups to screen plant cell cultures for novel, pharmacologically active principles. Many plants produce biologically active compounds but cannot be grown on a large scale-Here, plant suspensions cultures are receiving much attention and are used in the production of these compounds (e.g. 11).
It is beyond the scope of this paper to review the basic problems of how to establish high-yielding cell cultures (see references 12, 13, 14) , how to deal with the problem of the instability of high-producing cell lines (see references 15, 16, 17) , and how to improve the cells' productivity (see references 18, 19, 20) . We shall focus instead on advances made recently in the field of the large-scale cultivation of plant cells and the production of biologically active plant metabolites by fermentor-cultured plant cells.
Large-Scale Cultivation and Economic Considerations
In 1959, Tulecke and Nickell (47) were the first to report on the large-scale cultivation of plant cells. During these early studies steel tanks with volumes of up to 134 litres were already used. In the past few years, quite a lot of success has been achieved in the field of the fermentation and scale-up of cell suspensions. Plant cells are now cultivated in volumes of up to 75,000 litres (92), specific fermentor systems for plant cells have been developed, and productive cell culture systems have been established. (For recent reviews on mass culture systems for plant cells refer to 48, 49, 50, 51.)
Although plant cell cultures are regarded as an alternative to the agricultural production of natural products, biotechnological processes with plant cells are expected to be more costly than any of the microbial processes established so far, despite all the advances made in cell culture technology. Thus, chemicals which are candidates for production by plant cell cultures have to be of high economic value.
The most detailed cost analysis was produced by Goldstein et al. (52) . Their analyses give a good account of the different aspects that have to be considered in evaluating the cost of a plant cell culture process. Assuming that a conventional microbial fermentor is used to cultivate the plant cells, and that 10,000 kg of a fine chemical are produced per year, Goldstein and co-workers calculated a break-even against running costs if the product's selling price is US $ 1368 per kilogram. Other authors estimated the minimum selling prices more optimistically (17) or more pessimistically (3) ( Table 2 ). Yet, all the calculations available demonstrate that the produc- (Table 3) . As a consequence, the "preproduction phase",i.e. the time taken to grow the plant cells to the production scale is very time-consuming and may thus account for a significant part of the total cost of a biotechnological process. Usually, it takes about 20 to 40 days to establish a large-scale volume (Fig. 1) . As a consequence, utmost attention has to be given to sterility during the scale-up, sample-taking, and production cycle. In the respective publications, no one reports on the ratio of overall fermentor runs to sterile runs. Hence, it is difficult to give objective figures, but from our own experiences we know that during repeated batch culture, infections can be avoided over long periods of time (3 months) and that less than 10% of fermentations run in the batch mode will get infected.
Airlift Versus Stirred-Tank Bioreactors
Suitable bioreactors (Fig. 2) for plant cells had to be developed, since the cellulose cell walls seem to be quite sensitive to the high shear forces that are known to occur in microbial fermentation systems (stirred-tank bioreactors). One approach to the problem was the introduction of airlift bioreactors, where stirrers could be omitted. In 1977, Wagner and Vogelmann (59) reported on their investigations into the influence of different types of bioreactors on natural product synthesis. They already recognized that the low productivities achieved in reactors with turbine impellers resulted mainly from agitation problems. They explained their findings as a result of an oxygen limitation in stagnant zones together with mechanical damage to the cells in the turbulent region. From their results the authors concluded that the airlift system is superior to the stirred-tank system. The use of airlift bioreactors to cultivate This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
The Production of Secondary Metabolites by Plant Cells Cultivated in Bioreactors
Planta Medica 55(1989) 411 plant cells on a large scale has also been studied extensively by Fowler and co-workers (3).
It was found that the airlift bioreactors turned out to be problematic at high biomass levels. Here, efficient mixing and sufficient oxygen supply are not always guaranteed. In addition, the high aeration rates necessary cause trouble due to vigorous foaming. Therefore, stirrers have been invented which can be used to mix plant cell cultures grown in bioreactors.
Tanaka (62) , for example, has cultured Maclura tricupidata cells in bioreactors equipped with several types of stirrers (Fig. 3) . In these studies the best results were obtained when a paddle impeller was used to mix the plant cells. Ulbrich (53) compared various agitation modes in standard vessels and found that rosmarinic acid production with Col- ens blumel cells was best (3.3 g/l) when a helical stirrer, termed "module spiral stirrer" was used.
Cardenolide biotransformation, which will be reviewed in more detail later on, was improved when performed in stirred-tank reactors. When Digitalis lanata cells were cultivated in a 20-litre airlift bioreactor, 653mg )3-methyldigitoxin per litre were produced after 20 days of cultivation. If, on the other hand, stirrer-equipped bioreactors of similar size were used productivity increased, and 720 mg/l (helical stirrer) or 776 mg/l (spin stirrer) were produced (63) .
It was reported that oxygen tension in the culture medium influences alkaloid production by cultured plant cells (23, 64) . In the case of selected Berberis wilsoniae (Berberidaceae) cell cultures (65) , which are known to produce high amounts of protoberberine alkaloids, such as iatrorrhizine and berberine, the influence of dissolved oxygen on protoberberine production was investigated in more detail (60) . Maximum alkaloid production was achieved at dissolved oxygen levels of 50%. After 20 days of cultivation in a 20-litre airlift bioreactor about 3 g alkaloids per litre were produced, representing more than 10% of the cells ' (60% dissolved oxygen), productivity decreased and only 1 galkaloids per litre medium was produced.
Using a Biostat U 30 D bioreactor (Braun Co., Melsungen, FRG), the influence on alkaloid production of stirrer type, stirrer velocity, and dissolved oxygen (DO) level was examined. Due to the plant cells' sensitivity to high shear forces, it is generally advisable to use low stirrer velocities (about 50 to 200rpm, depending on the stirrer type used).
With the stirrer velocity set to 100 rpm, alkaloid production was clearly demonstrated to depend on the oxygen available in the medium. At a DO level of 20%, about 1.0 g protoberberines per litre were produced. If the level of DO was raised to 40%, productivity increased to some 1.4 g per litre. The alkaloid production could be further increased (to 2.4g/l) if the helical stirrer was run at 200rpm. This was mainly due to the far better growth of the cells as compared to their growth at 100rpm. Still higher stirrer velocities resulted in a reduced cell growth and hence reduced productivity (Fig, 4A) .
Several stirrer types (spin stirrer, bladed stirrer, helical stirrer, see Fig. 3 ) were tested and it was found that maximum alkaloid production is achieved if a bladed stirrer is used together with baffles (Fig. 4B ). In this case the level of alkaloids at the end of a fermentation run was as high as in the respective experiments where airlift bioreactors were used. Using either fermentor system, a productivity of 150 mgll*d could be achieved.
It is thus seen that plant cells maybe cultivated in conventional stirred-tank bioreactors, although at present no guidelines can be given concerning the best stirrer type. Depending on the cell culture used in each ofthe respective investigations, high growth rates as well as good production rates were achieved with either spin stirrers (63), helical stirrers (53), or bladed stirrers (60) .
Only recently, a novel fermentation mode was introduced by Fujita and Tabata (2). They designed a rotary drum-type tank (Fig. 2) and compared the production of shikonm by Lithosperraum erythrorhizon cells cultivated in conventional bioreactors with the productivity obtained in drum-type reactors of equal size. The authors found that, during scale-up to 1000 litres, productivity decreased when the stirred-tank mode was used. Using rotary drum tanks, on the other hand, they were able to scale up the volume to 1000 litres with no decrease in shikonin yield.
Batch Culture and Repeated Batch Culture
Although many plant cell cultures fail to synthesize secondary metabolites, they might be of some biotechnological importance due to their ability to perform specific chemical reactions ("biotransformations") . Like microbial processes, biotransformation reactions might be used in biotechnological processes with plant cells (66) .
In this context, we should refer to the successful cardenolide biotransformation with Digitalis lanata (Scrophulariaceae) cell cultures (67) . A semisynthetic cardenolide, )3-methyldigitoxin, is 1 23-hydroxylated by selected cell lines to 3-methyldigoxin with good yields and almost no side reaction (68). After a series of experiments with Digitalis cells cultivated in reactor vessels of various size, this biotransformation process could be further improved with regard to medium composition and the manner in which the substrate is fed to the cultured cells (61). Finally, Digitalis lanata cell suspensions were scaled up to 210 litres. The 1 213-hydroxylation of 3-methyldigitoxin to -methyldigoxin was performed in a 300-litre airlift bioreactor, yielding about 100 g 3-methyldigoxin after 18 to 20 days of fermentation (69) .
On the basis of our experiences in scaling up Digitalis lanata cells from the 300-mi level to the 300-litre bioreactor, we estimate that establishing an industrial scale volume of about 20,000 litres would last some 40 days. Only after that propagation phase can the biotransformation process be initiated. With a view to circumventing these rather long non-producing phases, semi-continuous fermentation systems were investigated. The fermentation mode used for the production of 3-methyldigoxin is the "repeated batch culture", where most of a given fermentor-cultured suspension is harvested from the stationary phase of the growth cycle. The bioreactor is then refilled with fresh medium after which the next production cycle can be initiated. In this way, a process was developed in which 513 g of )3-methyldigoxin were produced after 89 days of fermentation in a 300-litre airlift reactor (61). Digitalis cells were propagated in a growth medium and then transferred into production medium. Under optimum conditions all of the substrate added was biotransformed after 12 days of incubation, yielding the main product deacetyllanatoside C (88%) together with purpureaglycoside A, both of which accumulated in the cells (72, 73 ).
This process was successfully transferred to the 20-litre scale (airlift bioreactor) where 13.2g deacetyllanatoside C and 1.1 g purpureaglycoside A were produced from 11.7 g digitoxin after 9 days of incubation (94) (Fig. 5) .
The first commercial product derived from plant cell culture is obtained from cultured Lithospermum erythrorhizon cells. Shikonin, which is produced in the roots of Lithospermum erythrorhizon (Boraginaceae) is mainly used in Japan for treating injuries, burns, and haemorrhoids, and as a traditional silk dye. It takes about 4 years until Lithospermtun plants can be harvested for shikonin isolation. The chemical synthesis of shikonin has been reported, but since it took 12 reaction steps with a final yield ofjust 0.7%, chemical synthesis is not economical at the present time (24) .
In Japan, the Mitsui Petrochemical Industries have succeeded in establishing a two-stage fermentation process for the production of shikonin with suspension-cultured Lithospermum erythrorhizon cells (74, 75). The cells are proliferated in a propagation medium using a 200-litre stirred-tank bioreactor as the culture vessel. Under these conditions the cells fail to synthesize shikonin derivatives. When a sufficient cell mass is produced the cells are inoculated, together with a suitable production medium (76) , into a 750-litre bioreactor (Fig. 6) . After 14 days of culture in the production medium the cells are harvested and the red pigment is extracted from the cultured cells.
One single run in a 750-litre fermentor yields as much shikonin as 176,400 m2 fields of cultivated Lithospermum erythrorhizon plants, and it was estimated that production of shikonin using cell cultures is about 800 times more efficient than with field-grown plants (24) . Shikonin produced by cultured Lithospermum cells has been used for cosmetics in Japan since 1984.
A model process yielding the highest reported production rates is the production of rosmarinic acid by Coleus blumei (Lamiaceae) cells. In 1977, rosmarinic acid was first isolated form cultured Coleus blumei cells (77, 78). Then, the cellculture group of the A. Nattermann Company (Koln, FRG) developed a process for the production of rosmarinic acid on a large scale using Coleus blumei suspension cultures. It served mainly as a model system for process optimization in the field of plant cell culture technology. Detailed investigations into the culture medium composition and its influence on cell growth and product accumulation resulted in the formulation of two different media, which were found conducive to either good cell growth or rosmarinic acid production. A two-stage process was developed, in the first stage of which Coleus blumei cells are grown in a 42-litre airlift bioreactor (working volume 32 litres). When the appropriate cell density is reached, about 30-50% of the suspension are inoculated into a stirred-tank bioreactor (working volume 32 litres). Using this two-stage procedure, as much as 5.5g rosmarinic acid, representing 21% of the cells' dry weight, were produced per litre suspension after 6 days of cultivating the Coleus cells in the production medium (Fig. 7) . 
Morphological Differentiation as a Prerequisite for Product Accumulation
One characteristic feature of all organisms is that certain biochemical traits are only fully developed in specific organs or during specific developmental stages. This holds true in great measure for higher plants, where development, morphological differentiation, and secondary metabolism are closely connected. It has been reported repeatedly that undifferentiated plant cell tissues, which do not produce a certain metabolite, recover their synthetic capacity during morphogenesis. This makes it clear that we must correct the assumption that cell cultures, if to be used in bioreactor processes, have to be fine suspensions consisting of very small cell aggregates or even single cells.
Coleus forskohlii (Lamiaceae) forms a series of labdanes (80). One of these is forskolin, a compound which is known to stimulate adenylate cyclase, leading to an increase in cellular c-AMP level (81, 82) . Forskolin is usually produced by extraction from the roots of Coleus forskohlii plants.
Fine cell suspension cultures established from different Coleus forskohlu plants were unable to produce forskolin under the medium conditions necessary for optimum growth and viability. However, by changing the phytohormone balance in the medium, morphogenesis could be induced (83) and it was found that cell aggregates forming small roots produced considerable amounts of forskolin (83, 84). The cultivation conditions were optimized with regard to medium composition and root induction period, and finally a product yield of about 1 g/kg dry weight was achieved in experiments on the shake flask level.
The whole process was then scaled up to the 20-litre airlift fermentor. Cells were cultivated for 14 d under root-inducing conditions and were then transferred into the bioreactor. The plant tissue produced and accumulated forskoun from days 5 through 15, after which production and cell growth ceased. By the end of the fermentor run 134.3mg of forskolin were produced, accumulating in the tissue in concentrations of about 730mg/kg dry weight (85). Finally, Coleus forskohlii suspension cultures were scaled up to a 300-litre bioreactor and at the end of a 17-day fermentation run about 325 mg of forskolin were produced.
Perspectives
There is no doubt that plant cell cultures are a potential source of important secondary metabolites. We are now at a stage where most of the technical problems concerning the cultivation of plant cells on a large scale are solved. However, there are only very few cell culture processes, that have attracted industrial attention as yet. The main obstacle to a more common use of fermentor-cultured plant cells in industrial processes are biological problems and some of them will be described briefly.
The most severe problem is that it cannot be predicted whether the cells of a given plant species will produce the compound of interest when cultivated in vitro. Strangely enough, the very plant metabolites which are of the highest economic interest cannot yet be produced by plant cell cultures. Here, basic research is necessary concerning the enzymes involved in biosynthetic pathways and the regulation of these enzymes on both the physiological and genetic level. Molecular biology techniques have to be employed in investigations into the biochemistry of natural product synthesis. It has to be stressed that, in addition to the actual biosynthetic steps, other processes like product degradation, transport, and storage play important roles during the accumulation of plant secondary metabolites, and hence have to be elucidated on the enzymatic and molecular level. Only after detailed investigations, not just with model systems but with the plant species of economic interest itself, can that "black box", the cultured plant cell, be fully explored.
It was stressed that in the case of suspensioncultured Coleus forkohlii cells, forskolin production was only achieved with morphogenic, root-forming clumps (85). Similar results were obtained in studies performed by Luckner and coworkers (for a review, see 32) , who demonstrated that embryogenic cell clumps of Digitalis lanata can be cultivated in airlift bioreactors where they produce up to 1.5 mg cardenolides per litre.
Using these two examples, Coleus and Digitalis, we can describe another important problem. The Coleus clumps produce a metabolite pattern very similar to that of the Coleus forskohlii root, and hence a biotechnological process using fermentor-cultured Coleus clumps may be substituted for the field-grown plant. Embryogenic cultures of Digitalis, however, only synthesize cardenolides not used in therapy (86). Besides the fact, then, that productivity would have to be improved by a factor of 100 to 1000 before cardenolides can be produced economically, the main shortcoming of the Digitalis embryoid structures is thatthey produce the "wrong" cardenolides.
Only recently, a series of reports indicated the potential of Agrobacterium rhizogenes-transformed cells for This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited.
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Planta Medica 55(1989) 415 producing secondary metaholites (e.g. 87, 88, 89). In these cases morphogenesis, namely the formation of hairy roots, was a result of the incorporation of a piece of the microbe's DNA into the genome of the plant cell. In the biosynthesis of natural products normally produced in the roots of plants, this approach may yield a suitable culture material for the production of secondary metabolites in bioreactors.
While we are talking in terms of the genetic manipulation of plant cells, we should briefly discuss the potential of genetic engineering with regard to its application to recalcitrant cell cultures. Berlin (9) emphasized that enzymes connecting primary and secondary pathways may play important regulatory roles in the hiosynthesis of natural products. It is therefore necessary to isolate these enzymes from the appropriate source and characterize them. Investigations on the molecular level into the expression of the respective enzyme in both the synthesizing tissue and the non-productive cell culture have to follow. As a result a strategy for overcoming the problem of non-producing cell cultures can be developed using the genetic engineering toolbox. Since plant genes may be under the control of promotors regulated by developmental factors, one important step would be the construction of chimaeric concern is the future use of plant cell cultures as a source of plant secondary metabolites.
